CGG repeat length and AGG interruptions as indicators of fragile X–associated diminished ovarian reserve (original) (raw)
Refining the risk for fragile X–associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size
Heather Hipp
Genetics in Medicine, 2021
View PDFchevron_right
Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome
maria arroyo
Menopause, 2008
View PDFchevron_right
The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency
Joop Laven
Human reproduction (Oxford, England), 2014
View PDFchevron_right
Fragile X-Associated Diminished Ovarian Reserve and Primary Ovarian Insufficiency from Molecular Mechanisms to Clinical Manifestations
Limor Man
Frontiers in Molecular Neuroscience, 2017
View PDFchevron_right
Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity
Michael Epstein
Genetic Epidemiology, 2008
View PDFchevron_right
Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function
Elizabeth Ginsburg
Human Reproduction, 2011
View PDFchevron_right
PGD for fragile X syndrome: ovarian function is the main determinant of success
E. Levy-lahad
Human Reproduction, 2010
View PDFchevron_right
Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response
Jorge Ten
Human Reproduction, 2012
View PDFchevron_right
Ovarian Abnormalities in a Mouse Model of Fragile X Primary Ovarian Insufficiency
S. Jafar, Gloria Hoffman
Journal of Histochemistry & Cytochemistry, 2012
View PDFchevron_right
An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency
Bruce Rose
Journal of Assisted Reproduction and Genetics, 2020
View PDFchevron_right
Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)
Renate K Hukema
View PDFchevron_right
Evidence of Early Ovarian Aging in Fragile X Premutation Carriers
Ann Taylor
The Journal of Clinical Endocrinology & Metabolism, 2004
View PDFchevron_right
Deregulation of key signaling pathways involved in oocyte maturation in FMR1 premutation carriers with Fragile X-associated primary ovarian insufficiency
Xavier Estivill
Gene, 2015
View PDFchevron_right
AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome
Randi Hagerman
Genetics in medicine : official journal of the American College of Medical Genetics, 2012
View PDFchevron_right
Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure
Arie Smits
American Journal of Medical Genetics, 2003
View PDFchevron_right
Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation
Heather Hipp
Fertility and Sterility, 2021
View PDFchevron_right
Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
MARTA VALLES GUIMERA
Journal of Clinical Medicine
View PDFchevron_right
Blood expression profiles of fragile X premutation carriers identify candidate genes involved in neurodegenerative and infertility phenotypes
Montserrat Milà
Neurobiology of Disease, 2014
View PDFchevron_right
Expansion of the Fragile X CGG Repeat in Females with Premutation or Intermediate Alleles
Elke Holinski-feder
The American Journal of Human Genetics, 2003
View PDFchevron_right
Reproductive and menstrual history of females with fragile X expansions
James Webb
European Journal of Human Genetics, 2000
View PDFchevron_right
Expression of FMRpolyG in Peripheral Blood Mononuclear Cells of Women with Fragile X Mental Retardation 1 Gene Premutation
xuan nguyen
Genes, 2022
View PDFchevron_right
A study on the role of FMR1 CGG trinucleotide repeats in Jordanian poor ovarian responders
Nour Alahmad
Gene, 2021
View PDFchevron_right
Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives
Arie Smits
Human …, 2001
View PDFchevron_right
Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency
Anne Wheeler
Frontiers in Genetics, 2014
View PDFchevron_right
Association between idiopathic premature ovarian failure and fragile X premutation
Walter Vegetti
Human Reproduction, 2000
View PDFchevron_right
Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation
Walter Vegetti
Human Reproduction, 2005
View PDFchevron_right
Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age
Jennie Kline
Menopause, 2014
View PDFchevron_right
Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles
Kenneth Morgan
Human Molecular Genetics, 2002
View PDFchevron_right
FMR1 CGG-Repeat Instability in Single Sperm and Lymphocytes of Fragile-X Premutation Males
Sarah Nolin
The American Journal of Human Genetics, 1999
View PDFchevron_right
Predictors and risk model development for menopausal age in fragile X premutation carriers
Arie Smits
2011
View PDFchevron_right
Premature ovarian failure and FMR1 premutation co-segregation in a large Brazilian family
Marcelo Costa Lima
View PDFchevron_right